Mining FDA drug labels using an unsupervised learning technique - topic modeling
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The Food and Drug Administration (FDA) approved drug labels contain a broad array of information, ranging from adverse drug reactions (ADRs) to drug efficacy, risk-benefit consideration, and more. However, the labeling language used to describe these information is free text often containing ambiguous semantic descriptions, which poses a great challenge in retrieving useful information from the labeling text in a consistent and accurate fashion for comparative analysis across drugs. Consequently, this task has largely relied on the manual reading of the full text by experts, which is time consuming and labor intensive. Method: In this study, a novel text mining method with unsupervised learning in nature, called topic modeling, was applied to the drug labeling with a goal of discovering “topics” that group drugs with similar safety concerns and/or therapeutic uses together. A total of 794 FDA-approved drug labels were used in this study. First, the three labeling sections (i.e., Boxed Warning, Warnings and Precautions, Adverse Reactions) of each drug label were processed by the Medical Dictionary for Regulatory Activities (MedDRA) to convert the free text of each label to the standard ADR terms. Next, the topic modeling approach with latent Dirichlet allocation (LDA) was applied to generate 100 topics, each associated with a set of drugs grouped together based on the probability analysis. Lastly, the efficacy of the topic modeling was evaluated based on known information about the therapeutic uses and safety data of drugs. Results: The results demonstrate that drugs grouped by topics are associated with the same safety concerns and/or therapeutic uses with statistical significance (P<0.05). The identified topics have distinct context that can be directly linked to specific adverse events (e.g., liver injury or kidney injury) or therapeutic application (e.g., antiinfectives for systemic use). We were also able to identify potential adverse events that might arise from specific medications via topics. Conclusions: The successful application of topic modeling on the FDA drug labeling demonstrates its potential utility as a hypothesis generation means to infer hidden relationships of concepts such as, in this study, drug safety and therapeutic use in the study of biomedical documents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005 · cited 1×
“For example, studies based on the drug labeling have revealed that drugs receiving black box warnings appear more often in certain therapeutic categories than others [20,21].”
BackgroundOnline Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders
Hamosh, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.52 · Cited by 762
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406
Self-citationIdentifying biological concepts from a protein-related corpus with a probabilistic topic model
Zheng, B., McLean, D. C., & Lu, X. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-58 · Cited by 68 · cited 1×
“To the best of our knowledge, topic modeling has not yet been extensively investigated in medical and biological sciences [10-14] where textual documents are still the predominant resource used to archive research findings, clinical practices, regulatory actions, etc.”
Cited by
Miotto, R., Li, L., Kidd, B. A., & Dudley, J. T. (2016) · Scientific Reports · doi:10.1038/srep26094 · Cited by 1,710
Hashimoto, D. A., Witkowski, E., Gao, L., Meireles, O., & Rosman, G. (2020) · Anesthesiology · doi:10.1097/aln.0000000000002960 · Cited by 536
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
An overview of topic modeling and its current applications in bioinformatics
Liu, L., Tang, L., Dong, W., Yao, S., & Zhou, W. (2016) · SpringerPlus · doi:10.1186/s40064-016-3252-8 · Cited by 392
Information retrieval and text mining technologies for chemistry
Krallinger, M., Rabal, O., Lourenço, A., Oyarzabal, J., & Valencia, A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00851 · Cited by 281
Metadata
- Authors
- Bisgin, H., Liu, Z., Fang, H., Xu, X., & Tong, W.
- Venue
- BMC Bioinformatics
- Published
- 2011-10-18
- Volume
- 12
- Issue
- S10
- Pages
- S11-S11
- ISSN
- 1471-2105 (ISSN-L)
- OpenAlex
- W2120831232
- Cited by
- 107
- References
- 4
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mining FDA drug labels using an unsupervised learning technique - topic modeling. https://app.cochat.ai/papers/10.1186/1471-2105-12-s10-s11
- The paper
- Bisgin, H., Liu, Z., Fang, H., Xu, X., & Tong, W. (2011). Mining FDA drug labels using an unsupervised learning technique - topic modeling. BMC Bioinformatics. https://doi.org/10.1186/1471-2105-12-s10-s11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.